-entan
Drugs that block endothelin receptors, used in pulmonary hypertension.
- Drugs ending in -entan: 14
- Approved somewhere: 6
- With a US drug page: 6
- Stem
- -entan
- Class
- Drugs that block endothelin receptors, used in pulmonary hypertension
- Most common targets
- EDNRA (9), EDNRA, EDNRB (5), EDNRB (3), AGTR1 (1)
Approved and clinical-stage drugs in ChEMBL whose names ending in -entan, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Ambrisentan | Approved | EDNRA, EDNRB | Endothelin receptor, ET-A/ET-B antagonist |
| Aprocitentan | Approved | EDNRA, EDNRB | Endothelin receptor, ET-A/ET-B antagonist |
| Bosentan | Approved | EDNRA, EDNRB | Endothelin receptor, ET-A/ET-B antagonist |
| Macitentan | Approved | EDNRA, EDNRB | Endothelin receptor, ET-A/ET-B antagonist |
| Sparsentan | Approved | EDNRA, AGTR1 | Endothelin receptor ET-A antagonist |
| Atrasentan | Phase 3 | EDNRA | Endothelin receptor ET-A antagonist |
| Sitaxentan | Approved | EDNRA, EDNRB | Endothelin receptor, ET-A/ET-B antagonist |
| Avosentan | Phase 3 | EDNRA | Endothelin receptor ET-A antagonist |
| Clazosentan | Phase 3 | EDNRA | Endothelin receptor ET-A antagonist |
| Darusentan | Phase 3 | EDNRA, EDNRB | Endothelin receptor ET-A antagonist |
| Tezosentan | Phase 3 | EDNRA, EDNRB | Endothelin receptor ET-A antagonist |
| Zibotentan | Phase 3 | EDNRA | Endothelin receptor ET-A antagonist |
| Nebentan | Phase 2 | EDNRA | Endothelin receptor ET-A antagonist |
| Enrasentan | — | EDNRA, EDNRB | Endothelin receptor ET-A antagonist |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO